Literature DB >> 12833008

Repeated exposure to blue light does not improve psoriasis.

Catherine Maari1, Gilles Viau, Robert Bissonnette.   

Abstract

BACKGROUND: Increased endogenous levels of protoporphyrin IX (PpIX) have been reported in the skin of patients with psoriasis. Activation of PpIX with blue light after exogenous topical application of its precursor, aminolevulinic acid, can improve psoriasis. Light activation of endogenous PpIX for the treatment of psoriasis has never been studied.
OBJECTIVE: The purpose of this study was to determine the efficacy of multiple exposures to blue light in patients with plaque psoriasis.
METHODS: A total of 17 patients with plaque psoriasis presenting increased endogenous level of PpIX were enrolled. Of the 2 identified plaques on each patient, 1 was exposed to 10 J/cm(2) of blue light from a fluorescent panel 3 times per week for 4 consecutive weeks. Plaque severity was assessed in a blinded fashion. PpIX levels were measured with in vivo fluorescence spectroscopy weekly.
RESULTS: A single exposure to blue light induced almost complete photobleaching of PpIX. There was no significant difference between the mean psoriasis severity score of the plaques before and after 12 exposures to blue light.
CONCLUSION: Repeated exposure to blue light did not improve psoriasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12833008     DOI: 10.1067/mjd.2003.445

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  A Dynamic Model for Prediction of Psoriasis Management by Blue Light Irradiation.

Authors:  Zandra C Félix Garza; Joerg Liebmann; Matthias Born; Peter A J Hilbers; Natal A W van Riel
Journal:  Front Physiol       Date:  2017-01-26       Impact factor: 4.566

2.  Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment.

Authors:  Aleksandra Lesiak; Igor A Bednarski; Joanna Narbutt
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.